Fed. Circ. Revives Watson Challenge Of Seasonique IP

Law360, New York (March 28, 2011, 2:48 PM EDT) -- The Federal Circuit reversed a summary judgment win for Teva Women's Health Inc. on Friday, reviving Watson Laboratories Inc.'s challenge to the validity of a patent covering oral contraceptive Seasonique.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit issued a nonprecedential ruling agreeing with Watson's claim that a lower court incorrectly granted summary judgment of nonobviousness, remanding the case for further proceedings.

"Specifically, the district court erred in assessing the content and scope of the prior art, leading it to incorrectly...
To view the full article, register now.